TMED
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF
1W: -2.1%
1M: -7.4%
YTD: -7.5%
$33.22
-0.12 (-0.36%)
Weekly Expected Move ±2.5%
$32
$32
$33
$34
$35
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
56.0
★★★★★
Altman Z-Score
12.12
Safe
Weight Coverage
91%
of portfolio analyzed
Holdings Matched
101
with fundamental data
InsiderStreet Scorecard
★★★★★
56.0
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
12.12
Safe Zone (>2.99)
Piotroski F-Score
5.4 / 9
Moderate
Beneish M-Score
-12.71
Unlikely Manipulator
Credit Score
—
Earnings Quality
63.0 / 100
Portfolio Valuation
P/E
37.54x
P/B
5.02x
P/S
1.20x
EV/EBITDA
20.44x
EV/Revenue
1.18x
P/FCF
22.45x
P/OCF
19.45x
PEG
3.35x
Earnings Yield
2.66%
FCF Yield
4.45%
OCF Yield
5.14%
Median P/E
-2.94x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+17.4%
Net Income
+9.6%
EPS
+39.1%
FCF
+29.3%
EBITDA
+11.5%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+17.2%
Rev CAGR 5Y
+16.2%
EPS CAGR 3Y
+11.2%
EPS CAGR 5Y
+2.2%
FCF CAGR 3Y
+12.3%
FCF CAGR 5Y
+9.9%
EBITDA CAGR 3Y
+3.5%
EBITDA CAGR 5Y
+7.3%
Payout Ratio
14.42%
Buyback Yield
0.99%
Dividend Yield
0.42%
Total Shareholder Return
-3.81%
Earnings Stability
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 37.54 |
| Portfolio P/B | 5.02 |
| Portfolio P/S | 1.20 |
| EV/EBITDA | 20.44 |
| EV/Revenue | 1.18 |
| P/FCF | 22.45 |
| P/OCF | 19.45 |
| PEG | 3.35 |
| Earnings Yield | 2.66% |
| FCF Yield | 4.45% |
| OCF Yield | 5.14% |
| Median P/E | -2.94 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 24.25% |
| Operating Margin | 4.21% |
| Net Margin | 2.81% |
| FCF Margin | 5.19% |
| ROE | 12.03% |
| ROA | 4.17% |
| ROIC | 10.34% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.74 |
| Debt/Assets | 0.26 |
| Net Debt/EBITDA | 1.96 |
| Interest Coverage | 5.56 |
| Current Ratio | 1.05 |
| Quick Ratio | 0.84 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 17.43% |
| Net Income Growth | 9.63% |
| EPS Growth | 39.14% |
| FCF Growth | 29.28% |
| EBITDA Growth | 11.48% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 17.16% |
| Revenue CAGR 5Y | 16.20% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 11.19% |
| EPS CAGR 5Y | 2.21% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 12.32% |
| FCF CAGR 5Y | 9.88% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 3.46% |
| EBITDA CAGR 5Y | 7.31% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 9.31% |
| Net Income CAGR 5Y | 2.06% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 56.0 |
| IS Profitability | 45.8 |
| IS Balance Sheet | 57.8 |
| IS Earnings Quality | 63.0 |
| IS Growth | 54.1 |
| IS Value | 38.2 |
| IS Momentum | 69.7 |
| IS Safety | 82.7 |
| IS Quality | 64.7 |
| Altman Z-Score | 12.12 |
| Piotroski F-Score | 5.43 |
| Beneish M-Score | -12.71 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.42% |
| Payout Ratio | 14.42% |
| Buyback Yield | 0.99% |
| Total Shareholder Return | -3.81% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.760 |
| Earnings Stability | 0.552 |
| Earnings Persistence | 0.698 |
| Margin Stability | 0.770 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -2.94 |
| Median P/B | 3.58 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 91.17% |
| Holdings Matched | 101 |
| Total Holdings | 111 |